XML 30 R18.htm IDEA: XBRL DOCUMENT
v3.5.0.2

Condensed Consolidated Financial Statements Detail (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2016
Condensed Consolidated Financial Statements Detail [Abstract] |
Accrued and other liabilities | Accrued and other liabilities consisted of the following (in thousands):
|  | June 30, |  |  | December 31, |
|  | 2016 |  |  | 2015 |
Accrued payroll and other benefits |  | $ | 1,627 |  |  | $ | 2,156 |
Accrued clinical trial costs |  |  | 1,451 |  |  |  | 406 |
Accrued incentive compensation |  |  | 915 |  |  |  | 2,609 |
Deferred rent |  |  | 757 |  |  |  | 608 |
Accrued legal and accounting fees |  |  | 299 |  |  |  | 517 |
Other |  |  | 688 |  |  |  | 729 |
Total |  | $ | 5,737 |  |  | $ | 7,025 |
Outstanding securities considered anti-dilutive | The following table shows the weighted-average outstanding securities considered anti-dilutive and therefore excluded from the computation of diluted net loss per share of common stock (in thousands):
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
|  | 2016 |  |  | 2015 |  |  | 2016 |  |  | 2015 |
Common stock options and RSUs |  |  | 9,345 |  |  |  | 8,362 |  |  |  | 9,476 |  |  |  | 7,850 |
Warrants for common stock |  |  | 18,331 |  |  |  | 19,087 |  |  |  | 18,280 |  |  |  | 19,087 |
Total |  |  | 27,676 |  |  |  | 27,449 |  |  |  | 27,756 |  |  |  | 26,937 |

X
- Definition Tabular disclosure of the components of accrued liabilities. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Condensed Consolidated Financial Statements Detail [Abstract] + References No definition available. + Details
Name: | xoma_CondensedConsolidatedFinancialStatementsDetailAbstract
Namespace Prefix: | xoma_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration